M
Mark M. Davis
Researcher at Stanford University
Publications - 623
Citations - 84251
Mark M. Davis is an academic researcher from Stanford University. The author has contributed to research in topics: T cell & T-cell receptor. The author has an hindex of 144, co-authored 581 publications receiving 74358 citations. Previous affiliations of Mark M. Davis include Washington University in St. Louis & University of Chicago.
Papers
More filters
Book ChapterDOI
A High-Throughput Strategy for T-Cell Receptor Cloning and Expression.
TL;DR: In this paper , a recombination-based cloning protocol facilitates simple and rapid transfer of the T-cell receptor (TCR) transgene into different expression systems, which is a critical step for TCR characterization and epitope identification.
specific for U1-70 in lupus and mixed connective tissue disease
Nicole H. Kattah,Evan W. Newell,Justin A. Jarrell,Alvina D. Chu,Jianming Xie,Michael G. Kattah,Ofir Goldberger,Jessica Ye,Eliza F. Chakravarty,Mark M. Davis,Paul J. Utz +10 more
Journal ArticleDOI
Two New Families and a Literature Review of ELOVL4-Associated Spinocerebellar Ataxia Type 34.
Masahiro Nishide,K. Le Marquand,Mark M. Davis,Gabor Michael Halmagyi,Avi Fellner,Ramesh K. Narayanan,Marina L. Kennerson,Stephen W. Reddel,Lisa Worgan,Peter K. Panegyres,Kishore R. Kumar +10 more
TL;DR: In this article , the authors reported a large Italian-Maltese-Australian family with spinocerebellar ataxia, which is classically associated with a skin condition known as erythrokeratoderma.
Genetic markers of the antigen-specific t cell
Ruth Epstein,Neal Roehm,Philippa Marrack,John W. Kappler,Mark M. Davis,Stephen M. Hedrick,Melvin Cohn +6 more
Posted ContentDOI
Immuno-proteomic interrogation of dengue infection reveals novel HLA haplotype-specific MHC-I antigens
Kavya Swaminathan,Niclas Olsson,Peder Lund,Caleb D. Marceau,Lisa E. Wagar,Yuan Tian,John Sidney,Daniela Weiskopf,Karim Majzoub,Aruna D. deSilva,Eva Harris,Mark M. Davis,Alessandro Sette,Jan E. Carette,Joshua E. Elias +14 more
TL;DR: It is suggested that virus and host-derived MHC ligands have under-exploited potential for describing the cell biology of DENV infection, and as candidates for designing effective DENV vaccines.